Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2021.
The company has reported a fall of 39.53% in its net profit at Rs 192.69 crore for the quarter under review as compared to net profit of Rs 318.64 crore for the same quarter in the previous year. However, total income of the company decreased by 1.02% at Rs 1271.43 crore for Q1FY22 as compared Rs 1258.59 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 45.43% in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 164.52 crore for the quarter under review as compared to net profit of Rs 301.46 crore for the same quarter in the previous year. Total income of the company marginally increased by 1.02% at Rs 1327.91 crore for Q1FY22 as compared Rs 1341.64 crore for the corresponding quarter previous year.
